Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia

NCT00966017 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT00966017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00966017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
Lead sponsor
National Institute on Aging (NIA)
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2009
Completion date
February 28, 2014
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, down syndrome